Compare ANL & MPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANL | MPT |
|---|---|---|
| Founded | 2004 | 2003 |
| Country | Singapore | United States |
| Employees | N/A | 121 |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 998.8M | 983.5M |
| IPO Year | 2022 | 2004 |
| Metric | ANL | MPT |
|---|---|---|
| Price | $10.00 | $1.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | ★ $29.50 | $3.55 |
| AVG Volume (30 Days) | 229.1K | ★ 21.8M |
| Earning Date | 08-14-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 21.56% |
| EPS Growth | N/A | ★ 88.56 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $972,022,000.00 |
| Revenue This Year | $243.83 | N/A |
| Revenue Next Year | N/A | $4.41 |
| P/E Ratio | ★ N/A | $33.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.88 | $1.62 |
| 52 Week High | $17.25 | $6.47 |
| Indicator | ANL | MPT |
|---|---|---|
| Relative Strength Index (RSI) | 41.78 | 11.38 |
| Support Level | $8.95 | N/A |
| Resistance Level | $11.75 | $5.32 |
| Average True Range (ATR) | 1.03 | 0.19 |
| MACD | 0.20 | -0.03 |
| Stochastic Oscillator | 42.35 | 1.40 |
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.
Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. Its business strategy is to acquire and develop healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases, which require the tenant to bear of the costs associated with the property. The group's geographic areas are the United States, the United Kingdom, and All other countries.